Previously, it was described that type I interferon signaling, which overlaps with the innate immune response, is suppressed by PGE2 in COX-proficient melanomas, whereas the genetic ablation of Ptgs2 or Ptgs1 and -2 enables tumor recognition by the immune system [27]. This evidence concerns the gene PTGS1 and neoplasm.